For the Week of November 17, 2014
How does Medicare reimburse blood-clotting factors?
Under the hospital outpatient prospective payment system (OPPS), Medicare reimburses for blood-clotting factors under the same methodology as other nonpass-through separately payable drugs and biological, which is at the average sales price (ASP) plus 6 percent. It also pays a furnishing fee.
To view and archive of the Pharmacy Compliance Question fo the Week, click here